Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

108.09 +0.16 (+0.15%)
Official Closing Price Updated: 7:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,944,284
Open 106.75
Bid (Size) 102.00 (1)
Ask (Size) 108.09 (5)
Prev. Close 107.93
Today's Range 106.20 - 108.14
52wk Range 93.25 - 142.60
Shares Outstanding 1,750,942,289
Dividend Yield 1.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
 
Via Benzinga
3 Top Dividend Kings to Buy for the Long Haul
Dividend stocks are an easy option to boost income. 
Via The Motley Fool

Performance

YTD
-22.26%
-22.26%
1 Month
+10.25%
+10.25%
3 Month
+5.45%
+5.45%
6 Month
-7.27%
-7.27%
1 Year
-15.80%
-15.80%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Is This Stock-Split Stock a Buy For 2023?
Via The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
2 Reasons to Buy Abbott Labs and 1 Reason to Sell
Via The Motley Fool
2 Stocks Down 75% and 26% to Buy Right Now
Via The Motley Fool
8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
Better Dividend Stock: AbbVie or Viatris?
Via The Motley Fool
2 Unbeatable Dividend Stocks Billionaires Keep Buying in a Bear Market
Via The Motley Fool
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
Via The Motley Fool
Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.
Via The Motley Fool
FDA Outlines Strategy To Review Infant Formula Production Rules
Via Benzinga
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
Via The Motley Fool
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
Via The Motley Fool
Want Passive Income in 2023? Buy These Dividend Kings
Via The Motley Fool
7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond
Via InvestorPlace
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
Via Benzinga
Better Buy: Johnson & Johnson vs. Abbott Laboratories
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War
Via Benzinga
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
Via The Motley Fool
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
Via The Motley Fool
2 Reasons to Buy DexCom, and 1 Reason to Sell
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.